Irish professional services company Accenture and US-based cloud-based software company Salesforce have teamed up to develop a new cloud solution for life sciences companies, dubbed Salesforce Life Sciences Cloud.
Salesforce Life Sciences Cloud will help life sciences companies enhance their value and growth through data and artificial intelligence (AI).
Earlier this year, Accenture and Salesforce partnered to establish a generative AI hub to advance the deployment of generative AI for customer relationship management (CRM).
The expanded partnership will leverage their joint generative AI acceleration hub to help enhance employee productivity and customer experiences.
It will also leverage Salesforce Data Cloud and Einstein AI, Salesforce’s AI technology, to help enhance the productivity and experiences of healthcare professionals and patients.
Accenture enterprise and industry technologies lead and senior managing director Emma McGuigan said: “The rapid pace of science and technology advancements is making treatment decisions more complex. Data and AI will drive differentiation around how life sciences organizations engage with their customers.
“Together with Salesforce, we can help organizations establish a digital foundation to support omnichannel experiences across sales, service and marketing with data and intelligence at the core.”
Accenture and Salesforce have already developed several assets and accelerators, including a patient services Health Cloud assessment framework.
The framework evaluates legacy pharma patient services solutions to generate insights and a value case for Salesforce Life Sciences Cloud.
The companies also developed a pharmaceutical Data Cloud and Einstein AI accelerator, which leverages generative AI to provide a broad view of provider and patient data.
Accenture said that it will continue to develop complementary tools and methodologies to help clients test and pilot the new capabilities of Salesforce Life Sciences Cloud.
Accenture and Salesforce have worked together with Cencora, a pharmaceutical solutions provider previously known as AmerisourceBergen.
The Life Sciences Cloud solution is expected to provide Cencora with access to rich data and insights to improve its patient engagement with a digital-first capability at scale.
Cencora global pharma services data and platforms senior vice president Shannon Coven said: “Cencora is committed to leveraging new and emerging technologies, like generative AI, to deliver solutions that reduce potential barriers along the treatment journey and meet the needs of our biopharma partners, healthcare providers and the patients they serve.
“Together with Accenture and Salesforce, we are harnessing the power of data and AI to help improve outcomes and enhance the patient care experience.”
